FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897736788> ?p ?o ?g. }

• W2897736788 endingPage "137" @default.
• W2897736788 startingPage "129" @default.
• W2897736788 abstract "The oral formulation of the opioid antagonist naltrexone has shown limited effectiveness for treatment of opioid use disorder due to poor adherence. Long-acting injection naltrexone (XR-naltrexone), administered monthly, circumvents the need for daily pill taking, potentially improving adherence, and has been shown to be superior to placebo in reducing opioid use over 6 months of treatment. This open-label trial compared the outcomes of patients with opioid use disorder treated with XR-naltrexone or oral naltrexone in combination with behavioral therapy.Sixty opioid-dependent adults completed inpatient opioid withdrawal and were transitioned to oral naltrexone. They were stratified by severity of opioid use (six or fewer bags versus more than six bags of heroin per day) and randomly assigned (1:1) to continue treatment with oral naltrexone (N=32) or XR-naltrexone (N=28) for 24 weeks. The first dose of XR-naltrexone (380 mg) was administered prior to discharge, with monthly doses thereafter, and oral naltrexone was given in a 50-mg daily dose. All participants received weekly behavioral therapy to support treatment and adherence to naltrexone.A Cox proportional hazards model adjusting for race, gender, route of use, and baseline opioid use severity indicated that significantly more patients were retained in treatment for 6 months in the XR-naltrexone group (16 of 28 patients, 57.1%) than in the oral naltrexone group (nine of 32 patients, 28.1%) (hazard ratio=2.18, 95% CI=1.07, 4.43).Patients receiving XR-naltrexone had twice the rate of treatment retention at 6 months compared with those taking oral naltrexone. These results support the use of XR-naltrexone combined with behavioral therapy as an effective treatment for patients seeking opioid withdrawal and nonagonist treatment for preventing relapse to opioid use disorder." @default.
• W2897736788 created "2018-10-26" @default.
• W2897736788 creator A5001477267 @default.
• W2897736788 creator A5002859937 @default.
• W2897736788 creator A5008048834 @default.
• W2897736788 creator A5023883969 @default.
• W2897736788 creator A5039751213 @default.
• W2897736788 creator A5040029779 @default.
• W2897736788 creator A5073707428 @default.
• W2897736788 creator A5079969867 @default.
• W2897736788 creator A5083379140 @default.
• W2897736788 date "2019-02-01" @default.
• W2897736788 modified "2023-10-16" @default.
• W2897736788 title "A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder" @default.
• W2897736788 cites W1492318899 @default.
• W2897736788 cites W1520021447 @default.
• W2897736788 cites W1920799384 @default.
• W2897736788 cites W195764198 @default.
• W2897736788 cites W1969321130 @default.
• W2897736788 cites W1988132987 @default.
• W2897736788 cites W1989115284 @default.
• W2897736788 cites W1989741075 @default.
• W2897736788 cites W1990391721 @default.
• W2897736788 cites W1993437316 @default.
• W2897736788 cites W1999484743 @default.
• W2897736788 cites W2002469502 @default.
• W2897736788 cites W2009359984 @default.
• W2897736788 cites W2048019463 @default.
• W2897736788 cites W2052813313 @default.
• W2897736788 cites W2053509760 @default.
• W2897736788 cites W2056858493 @default.
• W2897736788 cites W2059678901 @default.
• W2897736788 cites W2076293542 @default.
• W2897736788 cites W2079969215 @default.
• W2897736788 cites W2087778252 @default.
• W2897736788 cites W2091022421 @default.
• W2897736788 cites W2091187494 @default.
• W2897736788 cites W2106293673 @default.
• W2897736788 cites W2121089728 @default.
• W2897736788 cites W2127673034 @default.
• W2897736788 cites W2140078950 @default.
• W2897736788 cites W2144978969 @default.
• W2897736788 cites W2145366493 @default.
• W2897736788 cites W2145849285 @default.
• W2897736788 cites W2153653527 @default.
• W2897736788 cites W2164678034 @default.
• W2897736788 cites W2171737529 @default.
• W2897736788 cites W2327042539 @default.
• W2897736788 cites W2415086269 @default.
• W2897736788 cites W2561135550 @default.
• W2897736788 cites W2570948865 @default.
• W2897736788 cites W2607023254 @default.
• W2897736788 cites W2768214444 @default.
• W2897736788 doi "https://doi.org/10.1176/appi.ajp.2018.17070732" @default.
• W2897736788 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6358483" @default.
• W2897736788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30336703" @default.
• W2897736788 hasPublicationYear "2019" @default.
• W2897736788 type Work @default.
• W2897736788 sameAs 2897736788 @default.
• W2897736788 citedByCount "57" @default.
• W2897736788 countsByYear W28977367882019 @default.
• W2897736788 countsByYear W28977367882020 @default.
• W2897736788 countsByYear W28977367882021 @default.
• W2897736788 countsByYear W28977367882022 @default.
• W2897736788 countsByYear W28977367882023 @default.
• W2897736788 crossrefType "journal-article" @default.
• W2897736788 hasAuthorship W2897736788A5001477267 @default.
• W2897736788 hasAuthorship W2897736788A5002859937 @default.
• W2897736788 hasAuthorship W2897736788A5008048834 @default.
• W2897736788 hasAuthorship W2897736788A5023883969 @default.
• W2897736788 hasAuthorship W2897736788A5039751213 @default.
• W2897736788 hasAuthorship W2897736788A5040029779 @default.
• W2897736788 hasAuthorship W2897736788A5073707428 @default.
• W2897736788 hasAuthorship W2897736788A5079969867 @default.
• W2897736788 hasAuthorship W2897736788A5083379140 @default.
• W2897736788 hasBestOaLocation W28977367881 @default.
• W2897736788 hasConcept C126322002 @default.
• W2897736788 hasConcept C142724271 @default.
• W2897736788 hasConcept C168563851 @default.
• W2897736788 hasConcept C170493617 @default.
• W2897736788 hasConcept C204787440 @default.
• W2897736788 hasConcept C27081682 @default.
• W2897736788 hasConcept C2775962371 @default.
• W2897736788 hasConcept C2777972943 @default.
• W2897736788 hasConcept C2778750930 @default.
• W2897736788 hasConcept C2779418921 @default.
• W2897736788 hasConcept C2781063702 @default.
• W2897736788 hasConcept C3019590667 @default.
• W2897736788 hasConcept C42219234 @default.
• W2897736788 hasConcept C71924100 @default.
• W2897736788 hasConceptScore W2897736788C126322002 @default.
• W2897736788 hasConceptScore W2897736788C142724271 @default.
• W2897736788 hasConceptScore W2897736788C168563851 @default.
• W2897736788 hasConceptScore W2897736788C170493617 @default.
• W2897736788 hasConceptScore W2897736788C204787440 @default.
• W2897736788 hasConceptScore W2897736788C27081682 @default.
• W2897736788 hasConceptScore W2897736788C2775962371 @default.
• W2897736788 hasConceptScore W2897736788C2777972943 @default.

• next